New hope in blood cancer battle: Next-Gen drug tested against standard therapy
NCT ID NCT05254743
First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 3 times
Summary
This study tests whether a newer drug called pirtobrutinib works better than the current standard drug ibrutinib for people with chronic lymphocytic leukemia or small lymphocytic lymphoma. About 737 adults who need treatment for their cancer will be randomly assigned to receive one of the two drugs. The goal is to see which drug shrinks tumors more effectively and keeps the cancer from growing longer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 737 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2022
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Confirmed diagnosis of CLL/SLL requiring therapy per iwCLL 2018 criteria * Part 1 - Known 17p deletion status (wildtype or deleted). Part 2 - Must have deletion of 17p as determined by FISH testing * Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 * Adequate organ function * Platelets greater than or equal to ≥ 50 x 10⁹/liter (L) or ≥30 x 10⁹/L in participants with documented bone marrow involvement considered to impair hematopoiesis, * Hemoglobin ≥8 grams/deciliter (g/dL) or ≥6 g/dL in participants with documented bone marrow involvement considered to impair hematopoiesis * Absolute neutrophil count ≥0.75 x 10⁹/L or ≥0.50 × 10⁹/L in participants with documented bone marrow involvement considered to impair hematopoiesis * Kidney function: Estimated creatinine clearance ≥30 milliliters per minute (mL/min) Exclusion Criteria: * Known or suspected Richter's transformation to diffuse large B-cell lymphoma (DLBCL), prolymphocytic leukemia, or Hodgkin's lymphoma at any time preceding enrollment * Known or suspected central nervous system (CNS) involvement * A significant history of renal, neurologic, psychiatric, endocrine, metabolic or immunologic disease * Active uncontrolled auto-immune cytopenia (e.g., autoimmune hemolytic anemia \[AIHA\], idiopathic thrombocytopenic purpura \[ITP\]) * Significant cardiovascular disease including ejection fraction \< 40% and any grade ongoing atrial fibrillation or atrial flutter * Hepatitis B or hepatitis C testing indicating active/ongoing infection, based on Screening laboratory tests * Active cytomegalovirus (CMV) infection * Active uncontrolled systemic bacterial, viral, or fungal infection * Known human immunodeficiency virus (HIV) infection, regardless of cluster of differentiation 4 (CD4) count * Clinically significant active malabsorption syndrome or other condition likely to affect GI absorption of the oral-administered study treatments * Ongoing inflammatory bowel disease * Previous treatment for CLL/SLL - Part 1: Treatment-naïve and previously treated, except prior exposure to BTK inhibitor (covalent or noncovalent). Part 2: participants must be treatment naïve * Concurrent use of investigational agent or anticancer therapy except hormonal therapy * Participants requiring therapeutic anticoagulation with warfarin or another Vitamin K antagonist * Use of \> 20 mg prednisone daily or equivalent dose of steroid at the time of first dose of study drug * Vaccination with a live vaccine within 28 days prior to randomization * Participants receiving chronic therapy with a strong cytochrome P450 (CYP)3A inhibitor (except posaconazole and voriconazole) which cannot be stopped within 3-5 half lives of the CYP3A inhibitor therapy prior to start of study drug treatment * Participants with known hypersensitivity, including anaphylaxis, to any component or excipient of pirtobrutinib or ibrutinib
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic lymphocytic leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
93 sites in 22 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
9 Eylul University Hospital
ACTIVE_NOT_RECRUITINGBalçova, 35100, Turkey (Türkiye)
-
AIDPORT Sp. z o.o.
RECRUITINGSkórzewo, 60-185, Poland
-
Acıbadem Maslak Hastanesi
COMPLETEDIstanbul, 34457, Turkey (Türkiye)
-
Affiliated Cancer Hospital of Xinjiang Medical University
ACTIVE_NOT_RECRUITINGÜrümqi, 830000, China
-
Alexander Fleming
RECRUITINGCiudad Autónoma de Buenos Aire, C1426ANZ, Argentina
-
American Hospital
RECRUITINGIstanbul, 34365, Turkey (Türkiye)
-
American Oncology Partners of Maryland, PA
RECRUITINGBethesda, Maryland, 20817, United States
-
Anhui Provincial Hospital
RECRUITINGHefei, 230001, China
-
Ankara University Medicine Hospital
RECRUITINGMamak, 06590, Turkey (Türkiye)
-
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo
RECRUITINGAlessandria, 15100, Italy
-
Azienda Unita Sanitaria Locale di Reggio Emilia
ACTIVE_NOT_RECRUITINGReggio Emilia, 42122, Italy
-
Blood Institute of the Chinese Academy of Medical science
ACTIVE_NOT_RECRUITINGTianjin, 300020, China
-
Bristol Haematology and Oncology Centre
RECRUITINGBristol, BS2 8ED, United Kingdom
-
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia
RECRUITINGSanto André, 09060-650, Brazil
-
CHD Vendee
RECRUITINGLa Roche-sur-Yon, 85000, France
-
CHRU De Tours
RECRUITINGTours, 37044, France
-
CHU de Nantes - Hotel Dieu
RECRUITINGNantes, 44093, France
-
California Cancer Associates for Research and Excellence
ACTIVE_NOT_RECRUITINGSan Marcos, California, 92069, United States
-
Cancer Care Associates Of York
ACTIVE_NOT_RECRUITINGYork, Pennsylvania, 17403, United States
-
Cancer Care Manitoba
ACTIVE_NOT_RECRUITINGWinnipeg, R3E 0V9, Canada
-
Cancer Specialists of North Florida -St Augustine
RECRUITINGSaint Augustine, Florida, 32086, United States
-
CeCim Biocinetic
ACTIVE_NOT_RECRUITINGSantiago, 8320000, Chile
-
Centre Antoine Lacassagne
RECRUITINGNice, 06189, France
-
Centre Hospitalier Lyon Sud
RECRUITINGPierre-Bénite, 69495, France
-
Centre Hospitalier Universitaire (Limoges) (CHU DUPUYTREN 1)
RECRUITINGLimoges, 87042, France
-
Centre Hospitalier du Mans
RECRUITINGLe Mans, 72000, France
-
Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen
RECRUITINGRouen, 76038, France
-
Centro Gaucho Integrado - Mae de Deus Center
RECRUITINGPorto Alegre, 90110270, Brazil
-
Centro Integrado de Oncologia de Curitiba
ACTIVE_NOT_RECRUITINGCuritiba, 80810050, Brazil
-
Centro Integrado de Pesquisa Clinica
RECRUITINGSão José do Rio Preto, 15090-000, Brazil
-
Centro de Investigaciones Clínicas Viña del Mar (CIC)
ACTIVE_NOT_RECRUITINGViña del Mar, 2520000, Chile
-
Chang Bing Show Chwan Memorial Hospital
RECRUITINGChanghua, 710, Taiwan
-
Chang Gung Memorial Hospital - Chiayi
RECRUITINGChiayi County, 61363, Taiwan
-
Clinica Universitaria De Navarra
RECRUITINGPamplona, 31008, Spain
-
Clínica de Nefrología, Urología y Enfermedades Cardiovasculares
RECRUITINGSanta Fe, 3000, Argentina
-
Debreceni Egyetem Orvos-es Egészsegtudomanyi Centrum
RECRUITINGDebrecen, 4004, Hungary
-
Dunedin Hospital
ACTIVE_NOT_RECRUITINGDunedin, 9016, New Zealand
-
Ege Üniversitesi
ACTIVE_NOT_RECRUITINGBornova, 35040, Turkey (Türkiye)
-
Fakultni Nemocnice Ostrava
RECRUITINGOstrava, 708 52, Czechia
-
Fakultni Nemocnice Plzen
RECRUITINGPilsen, 305 99, Czechia
-
Fakultni nemocnice Brno
RECRUITINGBrno, 62500, Czechia
-
Fakultni nemocnice Hradec Kralove
RECRUITINGHradec Králové, 500 05, Czechia
-
Fakultni nemocnice Kralovske Vinohrady
RECRUITINGPrague, 10034, Czechia
-
First Affiliated Hosp of College of Med, Zhejiang University
RECRUITINGHangzhou, 310003, China
-
Florida Cancer Specialists
RECRUITINGFort Myers, Florida, 33916-2233, United States
-
Florida Cancer Specialists East
RECRUITINGWest Palm Beach, Florida, 33401, United States
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, 200032, China
-
Fundação Pio XII - Hospital de Câncer de Barretos
RECRUITINGBarretos, 14784400, Brazil
-
Gazi University Faculty of Medicine
ACTIVE_NOT_RECRUITINGAnkara, 6500, Turkey (Türkiye)
-
Gemeinschaftspraxis für Hämatologie und Onkologie (Gefos)
ACTIVE_NOT_RECRUITINGDortmund, 44309, Germany
-
Guangxi Medical University Affiliated Tumor Hospital
RECRUITINGNanning, 530021, China
-
HOPE Centre
ACTIVE_NOT_RECRUITINGLeicester, LE1 5WW, United Kingdom
-
Hadassah Medical Center
RECRUITINGJerusalem, 9112001, Israel
-
Hainan General Hospital
ACTIVE_NOT_RECRUITINGHaikou, 570311, China
-
Hanusch Krankenhaus
ACTIVE_NOT_RECRUITINGVienna, 1140, Austria
-
Hematology Oncology Clinic
ACTIVE_NOT_RECRUITINGBaton Rouge, Louisiana, 70809, United States
-
Hemocentro Unicamp
RECRUITINGCampinas, 13083-878, Brazil
-
Hopital de L'Enfant Jesus
RECRUITINGQuébec, G1J 1Z4, Canada
-
Hopital de la Pitie Salpetriere
RECRUITINGParis, 75651, France
-
Hospital BP
RECRUITINGSão Paulo, 01321-001, Brazil
-
Hospital Clinic de Barcelona
ACTIVE_NOT_RECRUITINGBarcelona, 08036, Spain
-
Hospital Costa Del Sol
RECRUITINGMarbella, 29600, Spain
-
Hospital De Navarra
RECRUITINGPamplona, 31008, Spain
-
Hospital Duran i Reynals
ACTIVE_NOT_RECRUITINGL'Hospitalet de Llobregat, 08908, Spain
-
Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer
RECRUITINGCuritiba, 81520060, Brazil
-
Hospital Privado De Comunidad
ACTIVE_NOT_RECRUITINGMar del Plata, 7600, Argentina
-
Hospital Santa Marcelina
RECRUITINGSão Paulo, 08270-120, Brazil
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, 8035, Spain
-
Hospital Universitario Infanta Leonor-INTERNAL MED
RECRUITINGMadrid, 28031, Spain
-
Hospital Universitario Marqués de Valdecilla
RECRUITINGSantander, 39008, Spain
-
Hospital Universitario Puerta de Hierro Majadahonda
RECRUITINGMajadahonda, 28222, Spain
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Virgen Del Rocio
RECRUITINGSeville, 41013, Spain
-
Hospital Universitario Virgen Macarena
RECRUITINGSeville, 41009, Spain
-
Hospital Uopeccan - Centro de Pesquisa Clinica
RECRUITINGCascavel, 85806-300, Brazil
-
Hospital da Clinicas da Faculdade de Medicina da USP
RECRUITINGSão Paulo, 05403-000, Brazil
-
Hospital de Clínicas de Ribeirão Preto
RECRUITINGRibeirão Preto, 14051-140, Brazil
-
Hospital de la Santa Creu i Sant Pau
RECRUITINGBarcelona, 08025, Spain
-
Hunan Cancer Hospital
ACTIVE_NOT_RECRUITINGChangsha, 410013, China
-
Hôpital de Pontchaillou
RECRUITINGRennes, 35033, France
-
IRCCS Ospedale San Raffaele
RECRUITINGMilan, 20132, Italy
-
Inje Univ Busan Paik Hospital
RECRUITINGBusan, 47392, South Korea
-
Inmunocel
ACTIVE_NOT_RECRUITINGSantiago, 7580206, Chile
-
Instituto do Câncer - Hospital São Vicente de Paulo
RECRUITINGPasso Fundo, 99010090, Brazil
-
Istanbul University Istanbul Medicine Faculty
RECRUITINGFaith, 34732, Turkey (Türkiye)
-
Istituto Europeo di Oncologia
RECRUITINGMilan, 20141, Italy
-
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
RECRUITINGMeldola, 47014, Italy
-
Jiangxi Provincial Cancer Hospital
ACTIVE_NOT_RECRUITINGNanchang, 330029, China
-
KO-MED Centra Kliniczne
ACTIVE_NOT_RECRUITINGBiała Podlaska, 21500, Poland
-
Kelsey Research Foundation
ACTIVE_NOT_RECRUITINGHouston, Texas, 77025, United States
-
Klinika Hematoonkologii i Transplantacji Szpiku,Samodzielny Publiczny Szpital Kliniczny Nr 1
ACTIVE_NOT_RECRUITINGLublin, 20-081, Poland
-
Koo Foundation Sun Yan-Sen Cancer Center
RECRUITINGTaipei, 112, Taiwan
-
Kumamoto University Hospital
ACTIVE_NOT_RECRUITINGKumamoto, 860-8556, Japan
-
Lumi Research
RECRUITINGKingwood, Texas, 77339, United States
-
Markusovszky Egyetemi Oktatokorhaz
ACTIVE_NOT_RECRUITINGSzombathely, 9700, Hungary
-
Medical Oncology Associates, PS
RECRUITINGSpokane, Washington, 99208, United States
-
Middlemore Clinical Trials
RECRUITINGPapatoetoe, 2025, New Zealand
-
Momentum Clinical Research
RECRUITINGNewtown, 6242, New Zealand
-
MultiCare Health System Institute for Research and Innovation
ACTIVE_NOT_RECRUITINGSpokane, Washington, 99218, United States
-
National Cheng-Kung Uni. Hosp.
ACTIVE_NOT_RECRUITINGTainan, 704, Taiwan
-
One Clinical Research
ACTIVE_NOT_RECRUITINGNedlands, 6009, Australia
-
Onkologische Gemeinschaftspraxis / BAG
RECRUITINGDresden, 01307, Germany
-
Pacific Cancer Medical Center, Inc
RECRUITINGAnaheim, California, 92801, United States
-
Policlinico Sant'Orsola Malpighi
ACTIVE_NOT_RECRUITINGBologna, 40138, Italy
-
Pratia MCM Krakow
RECRUITINGKrakow, 30-510, Poland
-
Pratia Onkologia Katowice
RECRUITINGKatowice, 40519, Poland
-
Prisma Health Cancer Institute
ACTIVE_NOT_RECRUITINGGreenville, South Carolina, 29605, United States
-
Royal Victoria Hospital-Montreal
TERMINATEDMontreal, H3A 1A1, Canada
-
Samsung Medical Center
ACTIVE_NOT_RECRUITINGSeoul, 06351, South Korea
-
Sarah Cannon Research Institute SCRI
RECRUITINGNashville, Tennessee, 37203, United States
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Singleton Hospital
RECRUITINGSwansea, SA2 8QA, United Kingdom
-
Sociedad de Investigaciones Médicas Limitada
RECRUITINGTemuco, 4780000, Chile
-
Southern Medical University Nanfang Hospital
RECRUITINGGuangzhou, 510515, China
-
St Bartholomew's Hospital
ACTIVE_NOT_RECRUITINGLondon, EC1A 7BE, United Kingdom
-
St. Vincent Frontier Cancer Center
RECRUITINGBillings, Montana, 59102, United States
-
Stanford School of Medicine-Cancer Clinical Trials Office
RECRUITINGPalo Alto, California, 94305, United States
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, 510060, China
-
Szpital Uniwersytecki nr 1 im. Antoniego Jurasza
RECRUITINGBydgoszcz, 85-168, Poland
-
TOI Clinical Research
RECRUITINGCerritos, California, 90703, United States
-
Tel Aviv Sourasky Medical Center
ACTIVE_NOT_RECRUITINGTel Aviv, 6423906, Israel
-
The Catholic University of Korea-Seoul St. Mary's Hospital
RECRUITINGSeocho-Gu, 06591, South Korea
-
The Fourth Affiliated Hospital Zhejiang University School of Medicine
ACTIVE_NOT_RECRUITINGYiwu, 322000, China
-
The Perth Blood Institute
RECRUITINGWest Perth, 6005, Australia
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
ACTIVE_NOT_RECRUITINGHangzhou, 310009, China
-
The Second Hospital of Anhui Medical University
RECRUITINGHefei, 231200, China
-
The Second Xiangya Hospital of Central South University
ACTIVE_NOT_RECRUITINGChangsha, 410011, China
-
Tianjin Medical University General Hospital
ACTIVE_NOT_RECRUITINGTianjin, 300052, China
-
Tulane Cancer Center Office of Clinical Research
ACTIVE_NOT_RECRUITINGNew Orleans, Louisiana, 70112, United States
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
ACTIVE_NOT_RECRUITINGWuhan, 430022, China
-
Universitaetsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik und Poliklinik 1
ACTIVE_NOT_RECRUITINGDresden, 01307, Germany
-
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
RECRUITINGLeuven, 3000, Belgium
-
Universitätsklinikum Ulm
ACTIVE_NOT_RECRUITINGUlm, 89075, Germany
-
Uniwersytecki Szpital Kliniczny Klinika
RECRUITINGWroclaw, 50-367, Poland
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGdansk, 80-952, Poland
-
Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
RECRUITINGBotucatu, 18618-687, Brazil
-
VITAZ
RECRUITINGSint-Niklaas, B-9100, Belgium
-
Virginia Cancer Institute
RECRUITINGRichmond, Virginia, 23230, United States
-
Vseobecna fakultni nemocnice v Praze
RECRUITINGPrague, 12808, Czechia
-
Waikato Hospital
ACTIVE_NOT_RECRUITINGHamilton, 3204, New Zealand
-
Western Health, Sunshine Hospital
ACTIVE_NOT_RECRUITINGSt Albans, 3021, Australia
-
Wu Han Tongji Hospital
ACTIVE_NOT_RECRUITINGWuhan, 430030, China
-
Yamagata University Hospital
RECRUITINGYamagata, 990-9585, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two-Drug combo aims to push CLL into deep remission
- Can a new BTK inhibitor outsmart resistance in CLL?
- Can a new pill outsmart Drug-Resistant leukemia?
- Can engineered immune cells beat tough B-Cell cancers?
- Can a targeted drug outperform chemo for a common blood cancer?
- Can a triple drug combo outsmart High-Risk CLL?